EUVIMEDEUVIMED entdecken
Crossref

Jianpi Qingre Tongluo Prescription (Huangqin Qingrechubi Capsule) alleviates inflammation and hypercoagulability by inhibiting the JAK2/STAT3 pathway via CircRNA 104633 downregulation in gouty arthritis

Xianheng Zhang, Qi Han, Jian Liu, Yiming Chen, Xiang Ding, Xiaolu Chen

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Xianheng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China; Anhui Univ…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Arthritis, Gouty, RNA, Circular, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Anhui University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Gouty arthritis (GA) is characterized by intermittent inflammatory pain, which dramatically compromises the quality of life of patients. Huangqin Qingrechubi Capsule (HQC) is an empirical traditional Chinese medicine prescription used to treat GA for over 20 years, with favorable efficacy. However, little is known about the specific mechanism of action of HQC in GA treatment. PURPOSE: This study probed the mechanism of action of HQC in the treatment of GA from anti-inflammatory and anticoagulation aspects. METHODS: Initially, a retrospective clinical analysis was performed to observe the effects of HQC on inflammatory and coagulation indexes in GA patients. Subsequently, the expression of CircRNA 104633 and inflammatory and coagulation factors was detected in peripheral blood mononuclear cells (PBMCs) harvested from recruited GA patients before and after HQC treatment, followed by the analysis of the correlation between CircRNA 104633 and other indexes. The anti-inflammatory and anticoagulation mechanisms of HQC in GA treatment via CircRNA 104633 were further investigated through a co-culture model composed of GA-PBMCs and fibroblast-like synoviocytes (FLSs). Finally, a rat model of monosodium urate-induced GA was established for in vivo verification. RESULTS: HQC reduced the levels of HCRP, ESR, and D-D in GA patients. In the PBMCs of GA patients, HQC decreased CircRNA 104633 expression, and CircRNA 104633 expression was closely related to inflammatory and coagulation indexes. CircRNA 104633 upregulation fostered inflammation and hypercoagulability in GA by activating the JAK2/STAT3 pathway, whilst HQC reversed the imbalance of inflammatory and coagulation factors by downregulating CircRNA 104633. Furthermore, HQC played anti-inflammatory and anticoagulant roles in GA rats by blocking the JAK2/STAT3 pathway. CONCLUSION: HQC protects against inflammation and hypercoagulability in GA by inhibiting CircRNA 104633 and the JAK2/STAT3 pathway, which supports the development of therapeutic targets and drugs for GA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalArthritis, GoutyRNA, CircularAnti-Inflammatory AgentsThrombophiliaAnimalsJanus Kinase 2HumansMaleRatsDown-RegulationRats, Sprague-DawleySTAT3 Transcription FactorMiddle AgedFemaleSignal TransductionInflammationRetrospective StudiesAdultLeukocytes, Mononuclear

Stichwörter der Autor:innen

CircRNA 104633Gouty arthritisHuangqin qingrechubi capsuleHypercoagulabilityInflammationJAK2/STAT3 pathway

Substanzen

Janus Kinase 2Drugs, Chinese HerbalRNA, CircularJAK2 protein, humanSTAT3 Transcription FactorAnti-Inflammatory AgentsSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China; Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China.
  • Huainan Hospital of Traditional Chinese Medicine, Huainan, Anhui, 232000, China.
  • Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, China; Institute of Rheumatology, Anhui Academy of Traditional Chinese Medicine, Hefei,…
  • Anhui University of Chinese Medicine, Hefei, Anhui, 230012, China.

Förderung

  • Anhui University of Chinese Medicine

Zitieren

APA

Zhang, X., Han, Q., Liu, J., Chen, Y., Ding, X., & Chen, X. (2025). Jianpi Qingre Tongluo Prescription (Huangqin Qingrechubi Capsule) alleviates inflammation and hypercoagulability by inhibiting the JAK2/STAT3 pathway via CircRNA 104633 downregulation in gouty arthritis. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119552

Vancouver

Zhang X, Han Q, Liu J, Chen Y, Ding X, Chen X. Jianpi Qingre Tongluo Prescription (Huangqin Qingrechubi Capsule) alleviates inflammation and hypercoagulability by inhibiting the JAK2/STAT3 pathway via CircRNA 104633 downregulation in gouty arthritis. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119552

BibTeX
@article{Zhang2025,
  author = {Zhang, Xianheng and Han, Qi and Liu, Jian and Chen, Yiming and Ding, Xiang and Chen, Xiaolu},
  title = {Jianpi Qingre Tongluo Prescription (Huangqin Qingrechubi Capsule) alleviates inflammation and hypercoagulability by inhibiting the JAK2/STAT3 pathway via CircRNA 104633 downregulation in gouty arthritis},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119552}
}
Kostenlos starten →